Serum microRNAs as potential biomarkers of mandibular prognathism

被引:20
作者
Gu, Y. [1 ]
Zhang, Y. [1 ]
Zhao, C. [1 ]
Pan, Y. [1 ]
Smales, R. J. [2 ]
Wang, H. [1 ]
Ni, Y. [1 ]
Zhang, H. [1 ]
Ni, J. [1 ]
Ma, J. [1 ]
Wang, L. [1 ]
机构
[1] Nanjing Med Univ, Coll Stomatol, Inst Stomatol, Nanjing 210029, Jiangsu, Peoples R China
[2] Univ Adelaide, Sch Dent, Fac Hlth Sci, Adelaide, SA, Australia
基金
中国国家自然科学基金;
关键词
mandibular prognathism; microRNA; serum; marker; CIRCULATING MICRORNAS; EXPRESSION; CANCER; DIFFERENTIATION; CARCINOMA;
D O I
10.1111/odi.12073
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives: The aim of the study was to determine whether the expression levels of specific circulating serum microRNAs (miRNAs) are associated with mandibular prognathism (MP). MethodsSixty subjects in the early permanent dentition stage and 23 in the mixed dentition stage with MP were identified. Sixty-eight normal control subjects in the early permanent dentition stage and 24 in the mixed dentition stage were recruited for comparison. According to the microarray-based expression profiling, four serum miRNAs (let-7i-3p, miR-595, miR-16-2-3p, and miR-367-5p) were validated. ResultsIn the MP groups, let-7i-3p was significantly over-expressed in subjects in the early permanent (P<0.0005) and mixed (P<0.001) dentitions, and miR-595 was significantly under-expressed (P<0.004) in subjects in the early permanent (P<0.004) and mixed (P<0.0005) dentitions, compared with normal control groups. Multiple logistic regression analysis and receiver operating characteristic curve analysis revealed that let-7i-3p and miR-595 were able to significantly discriminate MP subjects from normal controls. ConclusionLet-7i-3p and miR-595 could be potential, non-invasive biomarkers for the accurate early detection and diagnosis of MP, which may result in improved clinical management.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 34 条
[1]  
Allwright W., 1964, INT DENT J, V14, P505
[2]   Treatment of mandibular prognathism [J].
Chang, Hong-Po ;
Tseng, Yu-Chuan ;
Chang, Hsin-Fu .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (10) :781-790
[3]   Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[4]  
Dietrich UC., 1970, RE CONG EUR ORTHOD S, P131
[5]   Circulating MicroRNAs in Patients with Active Pulmonary Tuberculosis [J].
Fu, Yurong ;
Yi, Zhengjun ;
Wu, Xiaoyan ;
Li, Jianhua ;
Xu, Fuliang .
JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (12) :4246-4251
[6]  
Ghafari J G, 1995, Semin Orthod, V1, P165, DOI 10.1016/S1073-8746(95)80020-4
[7]   Serum MicroRNAs Are Promising Novel Biomarkers [J].
Gilad, Shlomit ;
Meiri, Eti ;
Yogev, Yariv ;
Benjamin, Sima ;
Lebanony, Danit ;
Yerushalmi, Noga ;
Benjamin, Hila ;
Kushnir, Michal ;
Cholakh, Hila ;
Melamed, Nir ;
Bentwich, Zvi ;
Hod, Moshe ;
Goren, Yaron ;
Chajut, Ayelet .
PLOS ONE, 2008, 3 (09)
[8]  
GUYER EC, 1986, ANGLE ORTHOD, V56, P7
[9]   Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer [J].
Heneghan, Helen M. ;
Miller, Nicola ;
Lowery, Aoife J. ;
Sweeney, Karl J. ;
Newell, John ;
Kerin, Michael J. .
ANNALS OF SURGERY, 2010, 251 (03) :499-505
[10]   Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non-Small-Cell Lung Cancer [J].
Hu, Zhibin ;
Chen, Xi ;
Zhao, Yang ;
Tian, Tian ;
Jin, Guangfu ;
Shu, Yongqian ;
Chen, Yijiang ;
Xu, Lin ;
Zen, Ke ;
Zhang, Chenyu ;
Shen, Hongbing .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) :1721-1726